Association of Hippocampal Subfield Volumes with Amyloid-Beta Deposition in Alzheimer's Disease
- PMID: 35329851
- PMCID: PMC8955328
- DOI: 10.3390/jcm11061526
Association of Hippocampal Subfield Volumes with Amyloid-Beta Deposition in Alzheimer's Disease
Abstract
We investigated the relationship between hippocampal subfield volumes and cortical amyloid-beta (Aβ) deposition in Alzheimer’s disease (AD). Fifty participants (11 cognitively unimpaired [CU], 10 with mild cognitive impairment [MCI], and 29 with AD) who underwent 18F-florbetaben positron emission tomography, magnetic resonance imaging, and neuropsychological tests were enrolled. The hippocampal subfield volumes were obtained using an automated brain volumetry system with the Winterburn atlas and were compared among the diagnostic groups, and the correlations with the Aβ deposition and AD risk factors were determined. Patients with MCI and AD showed decreased volume in the stratum radiatum/lacunosum/moleculare (SRLM) of the cornu ammonis (CA)1 and CA4-dentate gyrus (DG) compared with the CU. Decreased SRLM and CA4-DG volumes were associated with an increased Aβ deposition in the global cortex (R = −0.459, p = 0.001; R = −0.393, p = 0.005, respectively). The SRLM and CA4-DG volumes aided in the distinction of AD from CU (areas under the receiver operating characteristic [AUROC] curve = 0.994 and 0.981, respectively, p < 0.001), and Aβ+ from Aβ− individuals (AUROC curve = 0.949 and 0.958, respectively, p < 0.001). Hippocampal subfield volumes demonstrated potential as imaging biomarkers in the diagnosis and detection of AD and Aβ deposition, respectively.
Keywords: Alzheimer’s disease; amyloid-beta; biomarker; hippocampal subfields.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
Hippocampal Stratum Radiatum, Lacunosum, and Moleculare Sparing in Mild Cognitive Impairment.J Alzheimers Dis. 2018;61(1):415-424. doi: 10.3233/JAD-170344. J Alzheimers Dis. 2018. PMID: 29171994 Free PMC article.
-
The Hippocampal Subfield Volume Reduction and Plasma Biomarker Changes in Mild Cognitive Impairment and Alzheimer's Disease.J Alzheimers Dis. 2024;98(3):907-923. doi: 10.3233/JAD-231114. J Alzheimers Dis. 2024. PMID: 38489180
-
Alzheimer's Disease Biomarkers Have Distinct Associations with Specific Hippocampal Subfield Volumes.J Alzheimers Dis. 2018;66(2):811-823. doi: 10.3233/JAD-180676. J Alzheimers Dis. 2018. PMID: 30320590
-
Hippocampal subfield volumetry in mild cognitive impairment, Alzheimer's disease and semantic dementia.Neuroimage Clin. 2013 Aug 14;3:155-62. doi: 10.1016/j.nicl.2013.08.007. eCollection 2013. Neuroimage Clin. 2013. PMID: 24179859 Free PMC article.
-
Why looking at the whole hippocampus is not enough-a critical role for anteroposterior axis, subfield and activation analyses to enhance predictive value of hippocampal changes for Alzheimer's disease diagnosis.Front Cell Neurosci. 2014 Mar 31;8:95. doi: 10.3389/fncel.2014.00095. eCollection 2014. Front Cell Neurosci. 2014. PMID: 24744700 Free PMC article. Review.
Cited by
-
Machine learning-based prediction of longitudinal cognitive decline in early Parkinson's disease using multimodal features.Sci Rep. 2023 Aug 14;13(1):13193. doi: 10.1038/s41598-023-37644-6. Sci Rep. 2023. PMID: 37580407 Free PMC article.
-
Elevated circulating levels of GFAP associated with reduced volumes in hippocampal subregions linked to mild cognitive impairment among community-dwelling elderly individuals.Front Aging Neurosci. 2024 Oct 29;16:1461556. doi: 10.3389/fnagi.2024.1461556. eCollection 2024. Front Aging Neurosci. 2024. PMID: 39534430 Free PMC article.
-
Genetic architecture of hippocampus subfields volumes in Alzheimer's disease.CNS Neurosci Ther. 2024 Mar;30(3):e14110. doi: 10.1111/cns.14110. Epub 2023 Feb 8. CNS Neurosci Ther. 2024. PMID: 36756718 Free PMC article.
-
Exploring the association between BIN1 gene polymorphisms and hippocampal subfield volume in community mild cognitive impairment.Front Neurol. 2025 Feb 12;16:1525664. doi: 10.3389/fneur.2025.1525664. eCollection 2025. Front Neurol. 2025. PMID: 40012995 Free PMC article.
-
Comparison of the efficacy of human umbilical cord mesenchymal stem cells conditioned medium and platelet-rich plasma on the hippocampus of STZ-induced rat model of Alzheimer's disease: A behavioral and stereological study.IBRO Neurosci Rep. 2023 Sep 14;15:209-217. doi: 10.1016/j.ibneur.2023.09.006. eCollection 2023 Dec. IBRO Neurosci Rep. 2023. PMID: 37780033 Free PMC article.
References
-
- Jack C.R., Jr., Lowe V.J., Senjem M.L., Weigand S.D., Kemp B.J., Shiung M.M., Knopman D.S., Boeve B.F., Klunk W.E., Mathis C.A. 11C PiB and structural MRI provide complementary information in imaging of Alzheimer’s disease and amnestic mild cognitive impairment. Brain. 2008;131:665–680. doi: 10.1093/brain/awm336. - DOI - PMC - PubMed
-
- Jack C.R., Wiste H.J., Vemuri P., Weigand S.D., Senjem M.L., Zeng G.A., Bernstein M.A., Gunter J.L., Pankratz V.S., Aisen P.S., et al. Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer’s disease. Brain. 2010;133:3336–3348. doi: 10.1093/brain/awq277. - DOI - PMC - PubMed
-
- Cardenas V.A., Chao L.L., Studholme C., Yaffe K., Miller B.L., Madison C., Buckley S.T., Mungas D., Schuff N., Weiner M.W. Brain atrophy associated with baseline and longitudinal measures of cognition. Neurobiol. Aging. 2011;32:572–580. doi: 10.1016/j.neurobiolaging.2009.04.011. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous